The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing
The National Health Service is in desperate need of extra billions in funding, according to an organisation representing hospitals, and has asked the government to prioritise the health ser
The government has suspended plans that would have put thousands of community pharmacies at risk of closure – but there is an urgent need for clarity, according to experts at a recent Quintiles
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas